GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hofseth BioCare ASA (OSTO:HBCO) » Definitions » Cyclically Adjusted Price-to-FCF

Hofseth BioCare ASA (OSTO:HBCO) Cyclically Adjusted Price-to-FCF : (As of Jun. 10, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Hofseth BioCare ASA Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Hofseth BioCare ASA Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Hofseth BioCare ASA's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hofseth BioCare ASA Cyclically Adjusted Price-to-FCF Chart

Hofseth BioCare ASA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Hofseth BioCare ASA Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Hofseth BioCare ASA's Cyclically Adjusted Price-to-FCF

For the Biotechnology subindustry, Hofseth BioCare ASA's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hofseth BioCare ASA's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hofseth BioCare ASA's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Hofseth BioCare ASA's Cyclically Adjusted Price-to-FCF falls into.



Hofseth BioCare ASA Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Hofseth BioCare ASA's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Hofseth BioCare ASA's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.051/132.6000*132.6000
=-0.051

Current CPI (Mar. 2024) = 132.6000.

Hofseth BioCare ASA Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 -0.754 97.500 -1.025
201409 -0.094 98.500 -0.127
201412 0.029 98.600 0.039
201503 -0.084 99.200 -0.112
201506 -0.394 100.100 -0.522
201509 -0.108 100.600 -0.142
201512 0.501 100.900 0.658
201603 -0.225 102.500 -0.291
201606 -0.503 103.800 -0.643
201609 -0.212 104.200 -0.270
201612 -0.042 104.400 -0.053
201703 -0.084 105.000 -0.106
201706 -0.056 105.800 -0.070
201709 0.017 105.900 0.021
201712 -0.045 106.100 -0.056
201803 -0.071 107.300 -0.088
201806 -0.019 108.500 -0.023
201809 -0.266 109.500 -0.322
201812 0.185 109.800 0.223
201903 -0.030 110.400 -0.036
201906 -0.034 110.600 -0.041
201909 -0.053 111.100 -0.063
201912 -0.048 111.300 -0.057
202003 -0.093 111.200 -0.111
202006 -0.094 112.100 -0.111
202009 -0.067 112.900 -0.079
202012 -0.083 112.900 -0.097
202103 -0.081 114.600 -0.094
202106 -0.059 115.300 -0.068
202109 -0.064 117.500 -0.072
202112 -0.072 118.900 -0.080
202203 -0.037 119.800 -0.041
202206 -0.132 122.600 -0.143
202209 -0.117 125.600 -0.124
202212 0.111 125.900 0.117
202303 -0.011 127.600 -0.011
202306 0.001 130.400 0.001
202309 0.007 129.800 0.007
202312 -0.026 131.900 -0.026
202403 -0.051 132.600 -0.051

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Hofseth BioCare ASA  (OSTO:HBCO) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Hofseth BioCare ASA Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Hofseth BioCare ASA's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Hofseth BioCare ASA (OSTO:HBCO) Business Description

Industry
Traded in Other Exchanges
Address
Kipervikgata 13, Aalesund, NOR, 6003
Hofseth BioCare ASA is a Norway based company engaged in the business of development, manufacturing, marketing and sale of marine ingredients such as oil, calcium and protein products. It is also involved in cooperation, participation, and ownership in the businesses engaged in related activities. The group operates in the business segment of producing salmon oil, soluble protein, calcium, and nonwater soluble protein. The brands under the company are OmeGo, PetGo, ProGo, and CalGo. The firm sells products to various segments of the human nutrition market such as sports nutrition, supplements, and health foods, as well as to the market within nutrition to pet and feed industry. It generates the majority of the revenue from the sale of salmon oil internationally.

Hofseth BioCare ASA (OSTO:HBCO) Headlines

No Headlines